metaLead AG is a preclinical stage biotech startup aiming to revolutionize the way we treat metal-related diseases, currently focusing on Wilson’s disease.
metaLead Therapeutics Secures CHF 1 Million Investment from the UZH Life Sciences Fund to Advance Treatment for Wilson Disease
| Building | C |
|---|---|
| Employees | 2 |
| Founding year | 2023 |
Home 
About us 
Offer 
News 
Financial support for start-ups in Basel 
Media 
Contact